BioMarin prices hemophilia gene therapy at nearly 29,000 euros per vial in Germany

[ad_1] Nov 28 (Reuters) – BioMarin Pharmaceutical (BMRN.O) said on Tuesday it will price its therapy for severe hemophilia A at 28,933.53 euros ($31,725.62) per vial for insurers covering a…

Australia regulator tells Medibank to set aside $167 mln after data breach

[ad_1] Shares down as much as 4.6%, worst day since Oct. 26 Medibank says has sufficient capital Capital returns apart from dividend unlikely in near-term-analyst SYDNEY, June 27 (Reuters) –…

Clover Health shares rebound after Palihapitiya comments on negative report

[ad_1] [1/4] The U.S. Securities and Exchange Commission logo adorns an office door at the SEC headquarters in Washington, June 24, 2011. REUTERS/Jonathan Ernst/File Photo Feb 5 (Reuters) – Shares…

Insurer AIG exceeds profit estimates on strong underwriting gains

[ad_1] May 4 (Reuters) – American International Group Inc (AIG.N) beat market estimates for first-quarter profit on Thursday, as record underwriting gains cushioned the blow from lower alternative investment returns.…

Prudential Financial profit misses on lower assets under management

[ad_1] May 2 (Reuters) – Prudential Financial Inc (PRU.N) reported a lower-than-expected quarterly profit on Tuesday, as the life insurer saw a decline in assets under management. The respite in…